VOSEVI (400 mg sofosbuvir, 100 mg velpatasvir, and 100 mg)

VOSEVI

VOSEVI

Sofosbuvir, Velpatasvir, and Voxilaprevir

400mg/100mg/100 mg

Gilead Sciences

Medical Use

VOSEVI is a prescription medication for adults with chronic hepatitis C virus (HCV) infection, either without cirrhosis or with compensated cirrhosis. It is used in the following cases:

  • -Patients with genotype 1, 2, 3, 4, 5, or 6 who have previously been treated with an HCV regimen that included an NS5A inhibitor.
  • -Patients with genotype 1a or 3 who have previously been treated with an HCV regimen that included sofosbuvir but not an NS5A inhibitor.

The safety and effectiveness of VOSEVI in children have not been established.

WhatsApp Chat